ATHA

Athira Pharma, Inc.

3.93 USD
+0.23 (+6.22%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Athira Pharma, Inc. stock is up 22.43% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 1 CALL, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 Feb 14:45 18 Oct, 2024 7.50 CALL 490 0
21 Feb 15:13 18 Oct, 2024 7.50 PUT 270 0

About Athira Pharma, Inc.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in Phase 3 and ACT-AD clinical trials for the treatment of Alzheimer's disease.